George A. Doss

3.5k citations

95 papers · 2.6k indexed · h-index 29

Co-authors: Thomas A. Baillie Ralph A. Stearns Wei Tang Margaret R. Davis Dennis Dean Kwan Leung Sijiu Shen Michael R. Marchick
Topics: Pharmacogenetics and Drug Metabolism (23 papers)Inflammatory mediators and NSAID effects (14 papers)Carbohydrate Chemistry and Synthesis (12 papers)
Cited by: Pharmacology Biochemistry
Journals: Journal of the American Chemical Society Journal of Agricultural and Food Chemistry Journal of Medicinal Chemistry
Partner nations: United States Japan Canada

In The Last Decade

George A. Doss

94 papers receiving 2.4k citations

Peers

Countries citing papers authored by George A. Doss

Since Specialization

Citations

This map shows the geographic impact of George A. Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Doss more than expected).

Fields of papers citing papers by George A. Doss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Doss. The network helps show where George A. Doss may publish in the future.

Co-authorship network of co-authors of George A. Doss

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Doss. A scholar is included among the top collaborators of George A. Doss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Doss. George A. Doss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glutathione S-Transferase Catalyzed Desulfonylation of a Sulfonylfuropyridine 2009 ·Drug Metabolism and Disposition ·Thomas J. Bateman,John S. Debenham,(unknown),(unknown),Thomas F. Walsh,Quang Truong,Scott A. Bradley,George A. Doss,Sanjeev Kumar,(unknown)	9
2	Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters 2008 ·Pharmaceutical Research ·Xiaoyan Chu,Yuexia Liang,Xiaoxin Cai,(unknown),(unknown),Kelem Kassahun,Magang Shou,Matthew P. Braun,George A. Doss,M. Reza Anari,Raymond Evers	16
3	Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Alexander Pasternak,(unknown),George A. Doss,Nancy N. Tsou,Gabor Butora,Pasquale P. Vicario,Julia M. Ayala,Mary Struthers,Julie A. DeMartino,Sander G. Mills,Lihu Yang	10
4	Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists 2007 ·Bioorganic & Medicinal Chemistry ·Gregori J. Morriello,Robert J. DeVita,Sander G. Mills,Jonathan R. Young,Peter Lin,George A. Doss,Gary G. Chicchi,Julie A. DeMartino,Marc M. Kurtz,Kwei‐Lan Tsao,Emma Carlson,(unknown),Alan Wheeldon,Susan Boyce,Neil Collinson,N.M.J. Rupniak,Stephen Moore	24
5	Absorption, Metabolism, and Excretion of [14C]MK-0524, a Prostaglandin D2 Receptor Antagonist, in Humans 2007 ·Drug Metabolism and Disposition ·Bindhu V. Karanam,Maria Madeira,Scott A. Bradley,Larissa Wenning,(unknown),(unknown),(unknown),(unknown),Brian Dean,George A. Doss,(unknown),Tami Crumley,Ajay Nirula,Eseng Lai	24
6	In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations 2007 ·Drug Metabolism and Disposition ·Ying Li,J. Greg Slatter,Zhoupeng Zhang,Yan Li,George A. Doss,Matthew P. Braun,Ralph A. Stearns,Dennis Dean,Thomas A. Baillie,Wei Tang	34
7	Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christopher W. Plummer,Paul E. Finke,Sander G. Mills,Junying Wang,Xinchun Tong,George A. Doss,Tung M. Fong,Julie Lao,Marie‐Therese Schaeffer,Jing Chen,Chun-Pyn Shen,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,Lex H.T. Van der Ploeg	46
8	Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole 2005 ·Bioorganic & Medicinal Chemistry Letters ·Wallace T. Ashton,(unknown),Hong Dong,Kathryn A. Lyons,Huaibing He,George A. Doss,Barbara Leiting,Reshma A. Patel,Joseph K. Wu,Frank Marsilio,Nancy A. Thornberry,Ann E. Weber	51
9	Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·John S. Debenham,(unknown),Thomas F. Walsh,Junying Wang,Xinchun Tong,George A. Doss,Julie Lao,Tung M. Fong,Marie‐Therese Schaeffer,Jing Chen Xiao,(unknown),Chun-Pyn Shen,Yue Feng,Donald J. Marsh,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,D. Euan MacIntyre,Lex H.T. Van der Ploeg,Mark T. Goulet	21
10	IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS 2004 ·Drug Metabolism and Disposition ·(unknown),George A. Doss,(unknown),Christopher J. Kochansky,Stella Vincent,Ronald B. Franklin,Bindhu V. Karanam	7
11	IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT 2004 ·Drug Metabolism and Disposition ·Randall R. Miller,George A. Doss,Ralph A. Stearns	14
12	Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in rhesus monkeys 2004 ·Archives of Biochemistry and Biophysics ·Brian Dean,Steve W. Chang,George A. Doss,Christopher D. King,Paul E. Thomas	27
13	Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Wallace T. Ashton,Hong Dong,(unknown),George A. Doss,Barbara Leiting,Reshma A. Patel,Joseph K. Wu,Frank Marsilio,Nancy A. Thornberry,Ann E. Weber	19
14	Potent Kv1.3 inhibitors from correolide—modification of the C18 position 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jianming Bao,(unknown),Frank Kayser,(unknown),Robert K. Baker,George A. Doss,John P. Felix,Randal M. Bugianesi,Robert S. Slaughter,Gregory J. Kaczorowski,María L. García,Sookhee Ha,(unknown),Gloria C. Koo,Kashmira Shah,Marty S. Springer,Mary Jo Staruch,William H. Parsons,Kathleen M. Rupprecht	18
15	Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate 2002 ·Drug Metabolism and Disposition ·Wei Tang,Ralph A. Stearns,Randall R. Miller,Jason S. Ngui,Robert J. Mathvink,Ann E. Weber,Gloria Y. Kwei,John R. Strauss,Carol Keohane,George A. Doss,Shuet-Hing Lee Chiu,Thomas A. Baillie	8
16	Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection 2002 ·Journal of Pharmaceutical and Biomedical Analysis ·Catherine Z. Matthews,Eric Woolf,Ralph S. Mazenko,(unknown),C.M. Chavez-Eng,M.L. Constanzer,George A. Doss,B.K. Matuszewski	38
17	Metabolism of A Dopamine D4-Selective Antagonist in Rat, Monkey, and Humans: Formation of A Novel Mercapturic Acid Adduct 2000 ·Drug Metabolism and Disposition ·(unknown),Prasad H. Kari,Margaret R. Davis,George A. Doss,Thomas A. Baillie,Kamlesh P. Vyas	9
18	Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. 1996 ·Drug Metabolism and Disposition ·Kwan Leung,Dosinda Cohn,Randall R. Miller,George A. Doss,Ralph A. Stearns,Richard E. Simpson,William P. Feeney,S H Chiu	8
19	N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes. 1994 ·Drug Metabolism and Disposition ·Su-Er W. Huskey,George A. Doss,R R Miller,William R. Schoen,S H Chiu	25
20	Microbial Transformation of L-696, 474, a Novel Cytochalasin as an Inhibitor of HIV-1 Protease 1993 ·Journal of Natural Products ·(unknown),George A. Doss,(unknown),Amy Hsu,Russell B. Lingham,Raymond F. White,Richard L. Monaghan	13

About George A. Doss

George A. Doss is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 95 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (23 papers), Inflammatory mediators and NSAID effects (14 papers) and Carbohydrate Chemistry and Synthesis (12 papers). The work is most often cited by research in Pharmacology (944 citations), Pharmacology (497 citations) and Biochemistry (205 citations). George A. Doss has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Thomas A. Baillie, Ralph A. Stearns, Wei Tang, Margaret R. Davis, Dennis Dean, Kwan Leung, Sijiu Shen, Michael R. Marchick, Lance R. Pohl and Kelem Kassahun. Their work appears in journals such as Journal of the American Chemical Society, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact